43192-32-1

Basic information

• Product Name: 2-bromo-5-ethoxybenzaldehyde
• Synonyms: 2-bromo-5-ethoxybenzaldehyde
• CAS NO: 43192-32-1
• Molecular Formula: C₉H₉BrO₂
• Molecular Weight: 229.07056
• EINECS: 256-136-8
• Mol File: 43192-32-1.mol

Chemical Properties

• Boiling Point: 298.3°C at 760 mmHg
• Flash Point: 134.2°C
• Appearance: /
• Density: 1.451g/cm³
• Vapor Pressure: 0.00128mmHg at 25°C
• Refractive Index: 1.573
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-bromo-5-ethoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-5-ethoxybenzaldehyde(43192-32-1)
• EPA Substance Registry System: 2-bromo-5-ethoxybenzaldehyde(43192-32-1)

Safety Data

• Hazardous Substances Data: 43192-32-1(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-bromo-5-ethoxybenzaldehyde is used as a building block for various pharmaceutical and agrochemical products. It serves as a key intermediate in the synthesis of complex organic molecules, contributing to the development of new drugs and agricultural chemicals.
Used in Heterocyclic Compound Synthesis:
2-bromo-5-ethoxybenzaldehyde is also used as a starting material for the synthesis of various heterocyclic compounds, which are important in the fields of pharmaceuticals, materials science, and agrochemicals due to their diverse range of biological activities and applications.
Used in Drug Development:
2-bromo-5-ethoxybenzaldehyde exhibits biological activities, including antifungal and antibacterial properties. These properties make it a potential lead compound in the development of new drugs, particularly for treating infections caused by resistant strains of bacteria and fungi.
Used in Chemical Research:
Due to its unique structure and reactivity, 2-bromo-5-ethoxybenzaldehyde is also utilized in chemical research to explore new reaction pathways, develop novel synthetic methods, and understand the fundamental principles of organic chemistry.
Safety Note:
It is important to handle 2-bromo-5-ethoxybenzaldehyde with caution, as it is toxic if ingested, inhaled, or comes into contact with the skin. Proper safety measures, such as wearing protective clothing and using appropriate containment, should be taken during its use in laboratories and industrial settings.

InChI:InChI=1/C9H9BrO2/c1-2-12-8-3-4-9(10)7(5-8)6-11/h3-6H,2H2,1H3

Upstream product

• 64-67-5 diethyl sulfate 
• 2973-80-0 2-bromo-5-hydroxybenzaldehyde 
• 75-03-6 ethyl iodide 

Downstream Products

• 888214-15-1 diethyl (2-bromo-5-ethoxyphenyl)-(hydroxy)-methyl-phosphonate 
• 1106867-72-4 (4-ethoxy-2-formylphenyl) boronic acid 

Relevant articles and documents

QUINAZOLINEDIONE DERIVATIVE

The present invention relates to quinazolinedione derivatives represented by formula (I) or pharmaceutically acceptable salts thereof.

SPIROXAZOLIDINONE COMPOUNDS

Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.

SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS

Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.

SUBSTITUTED SPIROCYCLIC AMINES USEFUL AS ANTIDIABETIC COMPOUNDS

Substituted spirocyclic amines of structural formula I are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, metabolic syndrome, depression, and anxiety.